P/E ratio for Dentsply Sirona (XRAY)
P/E ratio as of May 2024 (TTM): -28.4
According to Dentsply Sirona 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -28.38. At the end of 2022 the company had a P/E ratio of -7.20.
P/E ratio history for Dentsply Sirona from 2001 to 2023
PE ratio at the end of each year
| Year | P/E ratio | Change |
|---|---|---|
| 2022 | -7.20 | -123.37% |
| 2021 | 30.8 | -123.55% |
| 2020 | -131 | -372.95% |
| 2019 | 48.0 | -677.4% |
| 2018 | -8.31 | -13.19% |
| 2017 | -9.57 | -133.65% |
| 2016 | 28.4 | -15.88% |
| 2015 | 33.8 | 44.06% |
| 2014 | 23.5 | 6.01% |
| 2013 | 22.1 | 24.07% |
| 2012 | 17.8 | -11.27% |
| 2011 | 20.1 | 8.87% |
| 2010 | 18.5 | -2.84% |
| 2009 | 19.0 | 27.23% |
| 2008 | 14.9 | -43.58% |
| 2007 | 26.5 | 27.75% |
| 2006 | 20.7 | -78.77% |
| 2005 | 97.6 | 447.15% |
| 2004 | 17.8 | -12.31% |
| 2003 | 20.3 | 3.38% |
| 2002 | 19.7 | -8.26% |
| 2001 | 21.5 |
P/E ratio for similar companies or competitors
| Company | P/E ratio | P/E ratio differencediff. | Country |
|---|---|---|---|
 Danaher DHR | 33.0 | -216.36% | 🇺🇸 USA |
 3M MMM | -7.86 | -72.30% | 🇺🇸 USA |
 Align Technology
ALGN | 57.8 | -303.79% | 🇺🇸 USA |
 Integra LifeSciences IART | 22.5 | -179.40% | 🇺🇸 USA |
 Biolase
BIOL | -0.0006 | -100.00% | 🇺🇸 USA |
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.